Answers are grounded in this paper and cite their sources.
Septic shock may be treated by this new immunomodulatory approach: Active immunization of mice (three strains) with synthetic lipid X bisphosphonate glycoconjugates 1 and 2 resulted in significant protection (up to 94 %) against a sublethal challenge of lipid A (from E. coli serotype O111:B4).
No takes yet. Share an insight, caveat, or question.
Jones et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: